ARTHROPLASTY
Efficacy of combined IV/IA TXA administration in simultaneous bilateral TKA
This report has been verified
by one or more authors of the
original publication.
Knee. 2015 Mar;22(2):131-5
81 patients scheduled for simultaneous bilateral total knee arthroplasty were randomized to one of two groups: combined intravenous(IV)-intraarticular(IA) tranexamic acid (TXA) or placebo saline administration. The purpose of this study was to determine the efficacy of a combined TXA administration protocol for reducing blood loss postoperatively. Blood drainage, hemoglobin levels, and transfusion rates were assessed. Results demonstrated a significantly lower volume of blood drained after 24 hours in the TXA group compared to the placebo group, as well as a significantly smaller drop in Hb levels. Transfusion rate was 17.1% in the TXA group and 32.5% in the placebo group, though the difference was not statistically significant.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
